Testosterone metabolism, dose-response relationships and receptor polymorphisms: selected pharmacological/toxicological considerations on benefits versus risks of testosterone therapy in men. (Q35684578)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 2003

Language	Label	Description	Also known as
English	Testosterone metabolism, dose-response relationships and receptor polymorphisms: selected pharmacological/toxicological considerations on benefits versus risks of testosterone therapy in men.	scientific article published on December 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Europe PubMed Central

Testosterone metabolism, dose-response relationships and receptor polymorphisms: selected pharmacological/toxicological considerations on benefits versus risks of testosterone therapy in men. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Oettel M

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

230-256

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Testosterone replacement therapy in older adult men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Andropause: hormone replacement therapy in the ageing male

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Androgens and aging men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Androgen physiology: unsolved problems at the millennium

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Selected aspects of endocrine pharmacology of the aging male

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Testosterone therapy in men: clinical and pharmacological perspectives

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

An integrative review on current evidence of testosterone replacement therapy for the andropause

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Androgens and the ageing male and female

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Molecular action of androgens

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Androgen receptor (AR) coregulators: an overview

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Differential regulation of testosterone vs. 5alpha-dihydrotestosterone by selective androgen response elements

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Aromatase in skeletal muscle.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

A rapid, nongenomic, signaling pathway regulates the actin reorganization induced by activation of membrane testosterone receptors

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Non-genomic actions of sex steroid hormones.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Proof of the effect of testosterone on skeletal muscle

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Role of hormones in the pathogenesis and management of sarcopenia

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Double muscling in cattle due to mutations in the myostatin gene

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Correlation of clinical, endocrine and molecular abnormalities with in vivo responses to high-dose testosterone in patients with partial androgen insensitivity syndrome

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Androgens and the control of skeletal muscle protein synthesis.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Evidence for sex-dependent anabolic response to androgenic steroids mediated by muscle glucocorticoid receptors in the rat

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Rupture of the triceps tendon associated with steroid injections

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Testosterone administration to men increases hepatic lipase activity and decreases HDL and LDL size in 3 wk

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Androgens and coronary artery disease

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Androgens and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Testosterone suppression in men with prostate cancer is associated with increased arterial stiffness

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Androgen-Induced Vasorelaxation: A Potential Vascular Protective Effect

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Vascular reactivity in hypogonadal men is reduced by androgen substitution

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Physiological testosterone replacement and arterial endothelial function in men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Late onset of obesity in male androgen receptor-deficient (AR KO) mice

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Testosterone substitution of hypogonadal men prevents the age-dependent increases in body mass index, body fat and leptin seen in healthy ageing men: results of a cross-sectional study

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Is there a role for estrogens in the maintenance of men's health?

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Estradiol in elderly men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

The importance of oestrogens in males.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Physical provocation potentiates aggression in male rats receiving anabolic androgenic steroids

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Testosterone enhances aggression of wild-type mice but not those deficient in type I 5alpha-reductase

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Testosterone and dominance in men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Serum testosterone levels, mental disorders and criminal behaviour.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Plasma testosterone and pathological gambling

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Testosterone, sexuality and antisocial personality in rapists and child molesters: a pilot study

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Behavioural effects of androgen in men and women

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Psychosexual effects of three doses of testosterone cycling in normal men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Androgen-behavior correlations in hypogonadal men and eugonadal men. II. Cognitive abilities.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

The effect of parenteral testosterone replacement on prostate specific antigen in hypogonadal men with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Sex steroids and epidermal growth factor in benign prostatic hyperplasia (BPH).

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Testosterone: its role in development of prostate cancer and potential risk from use as hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Androgen replacement therapy and prostate safety

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Hormonal predictors of prostate cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Occult prostate cancer in men with low serum testosterone levels

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Association between prostate cancer and serum testosterone levels

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Comparative study of plasma steroid and steroid glucuronide levels in normal men and in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Serum steroids in normal males and patients with prostatic diseases

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Serum steroids in relation to benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Endocrine environment of benign prostatic hyperplasia: prostate size and volume are correlated with serum estrogen concentration

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Androgen administration in middle-aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volume

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Effect of obesity on prostatic hyperplasia: its relation to sex steroid levels.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Direct response of the murine prostate gland and seminal vesicles to estradiol.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Estrogen receptor-beta messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Leptin in relation to prostate cancer and benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Effects of estrogen deprivation on human benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Male pseudohermaphroditism due to steroid 5alpha-reductase 2 deficiency. Diagnosis, psychological evaluation, and management.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Low-dose estrogen supplementation improves vascular function in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Oral and transdermal estrogens both lower plasma total homocysteine in male-to-female transsexuals

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Oestrogen at the neonatal stage is critical for the reproductive ability of male mice as revealed by supplementation with 17beta-oestradiol to aromatase gene (Cyp19) knockout mice

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Men, bone and estrogen: unresolved issues.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Pharmacogenomics--drug disposition, drug targets, and side effects

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Differences in substrate and inhibitor kinetics of human type 1 and type 2 3beta-hydroxysteroid dehydrogenase are explained by the type 1 mutant, H156Y.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Polymorphic markers in the 5α‐reductase type II gene and the incidence of prostate cancer

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Significant ethnic variation in total and free testosterone concentration

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Luteinizing hormone beta polymorphism and risk of familial and sporadic prostate cancer.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Steroid hormone genotypes ARStuI and ER325 are linked to the progression of human prostate cancer.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Testosterone replacement therapy in male hypogonadism

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Mutation of the androgen receptor at amino acid 708 (Gly-->Ala) abolishes partial agonist activity of steroidal antiandrogens

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Androgen receptor mutations and androgen insensitivity

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Androgen insensitivity and male infertility

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Prostate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: a longitudinal pharmacogenetic study

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

CAG repeat length in the androgen receptor gene and gonadotrophin suppression influence the effectiveness of hormonal male contraception

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Development of models to predict anabolic response to testosterone administration in healthy young men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

The polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

The CAG repeat polymorphism within the androgen receptor gene and maleness

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

The Ageing Male. A consensus statement from the joint multidisciplinary working group of the German Society of Andrology, the German Society of Dermatology, the German Society of Endocrinology and the German Society of Urology

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Consensus Document on substitution therapy with testosterone in hypoandrogenic elderly men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE EVALUATION AND TREATMENT OF MALE SEXUAL DYSFUNCTION: A COUPLE'S PROBLEM-2003 UPDATE

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Glucocorticoid antagonism by exercise and androgenic-anabolic steroids

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Canadian practice recommendations for screening, monitoring and treating men affected by andropause or partial androgen deficiency

1 reference

https://api.crossref.org/works/10.1080%2F13685530312331309772

21 January 2018

Identifiers

10.1080/13685530312331309772

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35684578&oldid=2049208105"